Technical consultation: ECDC strategy to harness whole genome sequencing for cross-border outbreak and surveillance
The aims of the consultation were to review the draft strategy and discuss how to foster practical collaboration with European and global initiatives in this field.
Consultation of the Molecular Typing for Surveillance Task Force
The meeting, which brought together National Focal Points for Microbiology and for Surveillance, allowed to review proposals for the second edition of the ECDC roadmap for integration of molecular typing into outbreak investigation and EU surveillance.
Third Joint Workshop on AMR in Salmonella and Campylobacter
This workshop on AMR in Salmonella and Campylobacter was arranged in cooperation with the FWD Network and the EU reference laboratory for antimicrobial resistance network.
Moving towards better global foodborne disease surveillance
Almost 1 in 10 people worldwide fall ill every year after eating contaminated food which commonly causes bacterial diarrhoea, resulting in 230 000 deaths each year.
1st Hepatitis E virus network (HEVnet) meeting
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.
Call for scientific collaboration to support genomic-based surveillance of Neisseria gonorrhoeae-antimicrobial resistance at EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS) of Neisseria gonorrhoeae, carry out related data analyses, share results of the analyses with ECDC and the participants of the European Gonococcal Antimicrobial Surveillance Programme as well as visualise the results.
OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ summarises the EULabCap indicator results in the chapter on public health laboratory capacity to control infectious disease threats.